Warfarin is a blood thinner that has been used for many years. However, it has some drawbacks. It requires frequent blood tests to monitor the international normalized ratio (INR), and it interacts with many foods and medications. Direct-acting oral anticoagulants (DOACs) are a newer type of blood thinner that can be a better option for some people.
What are DOACs?
DOACs are a type of blood thinner that work differently than warfarin. They include apixaban, dabigatran, edoxaban, and rivaroxaban. Unlike warfarin, DOACs do not require frequent blood tests, and they have fewer interactions with food and medications.
Benefits of DOACs
- Efficacy - DOACs have been shown to be as effective as warfarin in preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) 1. They also have a lower risk of intracranial hemorrhage (bleeds in the brain/head) than warfarin 2.
- Convenience - DOACs are more convenient than warfarin because they do not require frequent blood tests and can be given safely in fixed doses 2. This makes them a more attractive option for patients who have difficulty adhering to a strict testing schedule.
- Fewer Interactions - DOACs have fewer interactions with food and medications than warfarin 2. This means that patients taking DOACs do not need to worry as much about what they eat or what other medications they are taking.
- Lower Risk of Bleeding - DOACs cause half as much life-threatening bleeding than warfarin 2. This makes them a safer option for patients who are at high risk of bleeding.
Conclusion
DOACs offer several benefits over warfarin, including efficacy, convenience, fewer interactions, and a lower risk of bleeding. If you are currently taking warfarin, talk to your doctor about whether switching to a DOAC is right for you.
1: [https://tehj.springeropen.com/articles/10.1186/s43044-022-00259-9]
2: [https://thrombosis.org/2020/11/doacs-vs-warfarin/]